Citadel Advisors - GALERA THERAPEUTICS INC ownership

GALERA THERAPEUTICS INC's ticker is GRTX and the CUSIP is 36338D108. A total of 48 filers reported holding GALERA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of GALERA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,224
-99.0%
12,700
-82.7%
0.00%
Q2 2023$229,623
+103.4%
73,597
+66.9%
0.00%
Q1 2023$112,896
+132.5%
44,100
+35.3%
0.00%
Q4 2022$48,550
-81.0%
32,584
-77.9%
0.00%
Q3 2022$256,000
+20.2%
147,252
-9.8%
0.00%
Q2 2022$213,000
-72.3%
163,330
-49.3%
0.00%
Q1 2022$768,000
-7.2%
322,284
+78.6%
0.00%
Q4 2021$828,000180,5000.00%
Other shareholders
GALERA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Sofinnova Investments, Inc. 3,083,712$40,582,0002.92%
Novo Holdings A/S 3,409,021$44,863,0002.89%
NEA Management Company, LLC 4,362,986$57,417,0002.72%
SPHERA FUNDS MANAGEMENT LTD. 471,439$6,204,0000.51%
RA Capital Management 1,054,178$13,873,0000.42%
Rock Springs Capital Management LP 500,000$6,580,0000.21%
Tekla Capital Management LLC 416,666$5,483,0000.21%
Blackstone Inc. 1,678,984$22,095,0000.14%
Perceptive Advisors 325,000$4,277,0000.08%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,300,000$17,108,0000.04%
View complete list of GALERA THERAPEUTICS INC shareholders